Mankind Pharma Limited
NSE: MANKIND · Healthcare
₹2,365.00
-9.50 (-0.40%)
Last close · 30 Aug 2026, 11:56 am IST
- Open
- ₹2,374.40
- Day high
- ₹2,374.40
- Day low
- ₹2,337.60
- Volume
- 4.16 L
- Prev close
- ₹2,374.50
HealthcareDrug Manufacturers - Specialty & GenericPart of:All NSE StocksNifty 200Nifty 500Nifty HealthcareNifty Midcap 100Nifty Midcap 150Nifty MidSmallcap 400Nifty Pharma
Price chart
Range
EMA
Also show
Fundamentals
Drug Manufacturers - Specialty & Generic
Valuation
- Market Cap
- 1,03,546 Cr
- Price
- 2,507.20
- P/E (TTM)
- 54.16
- P/E (Fwd)
- 35.19
- P/B
- 6.35
- EV/EBITDA
- 29.72
- EV/Revenue
- 7.56
- PEG
- —
- Div Yield
- 0.08%
- 52W High
- 2,674.00
- 52W Low
- 1,909.70
- Beta
- 0.45
Profitability & income
- Revenue (TTM)
- 14,278 Cr
- Net Income (TTM)
- 1,913 Cr
- EBITDA
- 3,630 Cr
- Gross Margin
- 70.13%
- Op. Margin
- 23.08%
- Net Margin
- 13.40%
- ROE
- 12.45%
- ROA
- 6.31%
- EPS (TTM)
- 46.29
- EPS (Fwd)
- 71.26
Financial health
- Total Debt
- 6,312 Cr
- Total Cash
- 2,208 Cr
- Debt/Equity
- 38.11
- Current Ratio
- 1.07
- Quick Ratio
- 0.61
- Book Value
- 394.85
- Free Cash Flow
- 1,675 Cr
- Op. Cash Flow
- 3,121 Cr
Growth
- Revenue Growth
- 11.80%
- Earnings Growth
- 31.70%
- Earnings QoQ
- 31.70%
Quarterly results
| Period | Revenue | Net Income | EBITDA | Op. Income | Gross Profit | Op. Cash Flow | Total Debt | Equity |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 3,443 Cr | 554 Cr | 1,024 Cr | 707 Cr | 2,485 Cr | — | 6,312 Cr | 16,300 Cr |
| 2025-12-31 | 3,567 Cr | 409 Cr | 889 Cr | 697 Cr | 2,589 Cr | — | — | — |
| 2025-06-30 | 3,570 Cr | 438 Cr | 930 Cr | 628 Cr | 2,517 Cr | — | — | — |
| 2025-03-31 | 3,079 Cr | 421 Cr | 937 Cr | 452 Cr | 2,204 Cr | — | 8,511 Cr | 14,332 Cr |
| 2024-12-31 | 3,199 Cr | 380 Cr | 896 Cr | 629 Cr | 2,267 Cr | — | — | — |
Annual results
| Period | Revenue | Net Income | EBITDA | Op. Income | Gross Profit | Op. Cash Flow | Total Debt | Equity |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 14,278 Cr | 1,913 Cr | 3,852 Cr | 2,835 Cr | 10,128 Cr | 3,121 Cr | 6,312 Cr | 16,300 Cr |
| 2025-03-31 | 12,207 Cr | 1,991 Cr | 3,558 Cr | 2,516 Cr | 8,638 Cr | 2,413 Cr | 8,511 Cr | 14,332 Cr |
| 2024-03-31 | 10,259 Cr | 1,913 Cr | 2,824 Cr | 2,239 Cr | 7,002 Cr | 2,152 Cr | 207 Cr | 9,363 Cr |
| 2023-03-31 | 8,749 Cr | 1,282 Cr | 2,037 Cr | 1,642 Cr | 5,787 Cr | 1,813 Cr | 170 Cr | 7,435 Cr |
| 2022-03-31 | — | — | — | — | — | — | — | — |
Figures in ₹ crore unless stated. Ratios and margins are trailing twelve months where marked TTM.
Want charts and signals for MANKIND?
Sign in for candlestick charts with Supertrend, MACD and VWAP overlays, plus watchlists and email alerts.
Sign in